Literature DB >> 20427998

Oliguria, creatinine and other biomarkers of acute kidney injury.

Claudio Ronco, Silvia Grammaticopoulos, Mitchell Rosner, Massimo De Cal, Sachin Soni, Paolo Lentini, Pasquale Piccinni.   

Abstract

Acute kidney injury (AKI) and fluid overload are conditions that require an early diagnosis and a prompt intervention. The recognition of these pathologic conditions is possible in the early stages if specific signs and symptoms are taken into account. Among them, oliguria represents an important sign. Reduced urine output for a certain number of hours may be an important sign of kidney dysfunction. This must be evaluated in conjunction with other factors such as hydration status and use of drugs. At the same time, traditional markers of kidney function such as urea nitrogen and creatinine must be evaluated in light of a possible altered balance. Increased levels may be due to reduced kidney function but also increased generation or altered solute distribution space due to non-optimal hydration status. Finally, novel biomarkers for renal tissue damage are becoming popular. Molecules such as NGAL or cystatin C may become altered well before creatinine or oliguria signal a condition of reduced kidney function. Here, the difference between insult and dysfunction becomes evident. Novel biomarkers seem to enable the clinician to make early diagnosis of kidney damage, distinguishing between AKI and acute kidney failure. Reduced glomerular filtration rate is, in fact, a late event in the continuum of the AKI syndrome. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20427998     DOI: 10.1159/000313725

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  11 in total

1.  Serum neutrophil gelatinase-associated lipocalin and interleukin-18 as predictive biomarkers for delayed graft function after kidney transplantation.

Authors:  Eun Young Lee; Myoung Soo Kim; Yongjung Park; Hyon-Suk Kim
Journal:  J Clin Lab Anal       Date:  2012-07       Impact factor: 2.352

Review 2.  Emergence of biomarkers in nephropharmacology.

Authors:  Enver Khan; Vecihi Batuman; Juan J L Lertora
Journal:  Biomark Med       Date:  2010-12       Impact factor: 2.851

Review 3.  Subclinical AKI--an emerging syndrome with important consequences.

Authors:  Michael Haase; John A Kellum; Claudio Ronco
Journal:  Nat Rev Nephrol       Date:  2012-09-25       Impact factor: 28.314

4.  Stroke volume variation and serum creatinine changes during abdominal aortic aneurysm surgery: a time-integrated analysis.

Authors:  Paolo Lentini; Luca Zanoli; Pasquale Fatuzzo; Faeq Husain-Syed; Rudi Stramanà; Diego Cognolato; Vincenzo Catena; Marco Baiocchi; Antonio Granata; Roberto Dell'Aquila
Journal:  J Nephrol       Date:  2018-01-17       Impact factor: 3.902

5.  Acute kidney injury: controversies revisited.

Authors:  Kenneth Yong; Gursharan Dogra; Neil Boudville; Mary Pinder; Wai Lim
Journal:  Int J Nephrol       Date:  2011-04-14

6.  Oliguria as predictive biomarker of acute kidney injury in critically ill patients.

Authors:  John R Prowle; Yan-Lun Liu; Elisa Licari; Sean M Bagshaw; Moritoki Egi; Michael Haase; Anja Haase-Fielitz; John A Kellum; Dinna Cruz; Claudio Ronco; Kenji Tsutsui; Shigehiko Uchino; Rinaldo Bellomo
Journal:  Crit Care       Date:  2011-07-19       Impact factor: 9.097

7.  Pharmacological evaluation of embelin - chitosan nanoparticles as an antidiabetic agent.

Authors:  Saba Maanvizhi; Narayanaswamy Radhakrishnan; Chitra Krishnan; Arumugam Gnanamani
Journal:  Indian J Pharmacol       Date:  2022 Mar-Apr       Impact factor: 2.833

Review 8.  Cockcroft-Gault revisited: New de-liver-ance on recommendations for use in cirrhosis.

Authors:  Gianni B Scappaticci; Randolph E Regal
Journal:  World J Hepatol       Date:  2017-01-28

9.  Preconditioning by aerobic exercise reduces acute ischemic renal injury in rats.

Authors:  Weslei V de Lima; Iria Visona; Nestor Schor; Waldemar S Almeida
Journal:  Physiol Rep       Date:  2019-07

10.  Lactobacillus rhamnosus Reduces Blood Glucose Level through Downregulation of Gluconeogenesis Gene Expression in Streptozotocin-Induced Diabetic Rats.

Authors:  Eko Farida; Lilis Nuraida; Puspo E Giriwono; Betty S L Jenie
Journal:  Int J Food Sci       Date:  2020-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.